招商公路(001965.SZ)一季度經營業績迎來良好開局,歸母淨利潤同比增23.57%
格隆匯5月9日丨招商公路(001965.SZ)於2023年5月8日15:00-16:00召開2022年度暨2023年一季度業績説明會,就“一季度業績情況?”,公司表示,4月28日,招商公路披露了2023年一季度報吿,2023年一季度,招商公路實現營業收入20.26億元,同比增長16.30%;歸母淨利潤13.49億元,同比增長23.57%;扣非歸母淨利潤13.39億元,同比增長24.14%;基本每股收益0.2109元/股,同比增長25.46%。一季度公司經營業績迎來良好開局。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.